Segui
Francesco Alessandro Mistretta
Francesco Alessandro Mistretta
MD, Dept. of Urology, European institute of Oncology (IEO), Milan, Italy
Email verificata su ieo.it
Titolo
Citata da
Citata da
Anno
Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta‐analysis
AAC Grasso, FA Mistretta, M Sandri, G Cozzi, E De Lorenzis, M Rosso, ...
BJU international 118 (1), 20-34, 2016
862016
Radiomics in prostate cancer: An up-to-date review
M Ferro, O de Cobelli, G Musi, F Del Giudice, G Carrieri, GM Busetto, ...
Therapeutic Advances in Urology 14, 17562872221109020, 2022
712022
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses
A Larcher, N Fossati, F Mistretta, G Lughezzani, G Lista, P Dell’Oglio, ...
Urologic Oncology: Seminars and Original Investigations 33 (1), 22. e1-22. e9, 2015
622015
Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2] proPSA (p2PSA),% p2PSA, and prostate health index in men with a total …
M Lazzeri, A Abrate, G Lughezzani, GM Gadda, M Freschi, F Mistretta, ...
Urology 83 (3), 606-612, 2014
622014
Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes
G Musi, FA Mistretta, C Marenghi, A Russo, M Catellani, S Nazzani, ...
Journal of Endourology 32 (3), 257-263, 2018
542018
Clinical performance of serum isoform [‐2] pro PSA (p2PSA), and its derivatives% p2PSA and the Prostate Health Index, in men aged< 60 years: results from a multicentric E …
N Fossati, M Lazzeri, A Haese, T McNicholas, A de la Taille, NM Buffi, ...
BJU international 115 (6), 913-920, 2015
512015
Clinical performance of serum isoform [‐2] pro PSA (p2PSA), and its derivatives% p2PSA and the Prostate Health Index, in men aged< 60 years: results from a multicentric E …
N Fossati, M Lazzeri, A Haese, T McNicholas, A de la Taille, NM Buffi, ...
BJU international 115 (6), 913-920, 2015
512015
Clinical use of [-2] proPSA (p2PSA) and its derivatives (% p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature
A Abrate, G Lughezzani, GM Gadda, G Lista, E Kinzikeeva, N Fossati, ...
Korean journal of urology 55 (7), 436, 2014
492014
Contemporary national assessment of robot-assisted surgery rates and total hospital charges for major surgical uro-oncological procedures in the United States
E Mazzone, FA Mistretta, S Knipper, Z Tian, A Larcher, H Widmer, K Zorn, ...
Journal of endourology 33 (6), 438-447, 2019
452019
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients
M Ferro, G Musi, A Serino, G Cozzi, FA Mistretta, B Costa, R Bianchi, ...
Urologia internationalis 102 (1), 43-50, 2019
452019
In-hospital length of stay after major surgical oncological procedures
S Nazzani, F Preisser, E Mazzone, Z Tian, FA Mistretta, SF Shariat, ...
European Journal of Surgical Oncology 44 (7), 969-974, 2018
392018
Bladder cancer and urothelial impairment: the role of TRPV1 as potential drug target
F Mistretta, NM Buffi, G Lughezzani, G Lista, A Larcher, N Fossati, ...
BioMed research international 2014, 2014
342014
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
M Ferro, F Crocetto, B Barone, F Del Giudice, M Maggi, G Lucarelli, ...
Therapeutic Advances in Urology 15, 17562872231164803, 2023
322023
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre E uropean …
A Abrate, M Lazzeri, G Lughezzani, N Buffi, V Bini, A Haese, A de la Taille, ...
BJU international 115 (4), 537-545, 2015
312015
Contemporary comparison of clinicopathologic characteristics and survival outcomes of prostate ductal carcinoma and acinar adenocarcinoma: a population-based study
S Knipper, F Preisser, E Mazzone, FA Mistretta, Z Tian, A Briganti, ...
Clinical genitourinary cancer 17 (3), 231-237. e2, 2019
302019
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer
M Ferro, G Di Lorenzo, C Buonerba, G Lucarelli, GI Russo, F Cantiello, ...
Journal of cancer 9 (22), 4250, 2018
292018
Impact of age on outcomes of patients with pure carcinoma in situ of the bladder: multi-institutional cohort analysis
M Ferro, S Chiujdea, G Musi, G Lucarelli, F Del Giudice, R Hurle, ...
Clinical Genitourinary Cancer 20 (2), e166-e172, 2022
282022
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma
S Nazzani, E Mazzone, F Preisser, Z Tian, FA Mistretta, SF Shariat, ...
European Journal of Surgical Oncology 45 (7), 1238-1245, 2019
282019
Multiparametric magnetic resonance imaging second opinion may reduce the number of unnecessary prostate biopsies: time to improve radiologists’ training program?
S Luzzago, G Petralia, G Musi, M Catellani, S Alessi, E Di Trapani, ...
Clinical Genitourinary Cancer 17 (2), 88-96, 2019
282019
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve …
R Bianchi, G Cozzi, G Petralia, S Alessi, G Renne, D Bottero, A Brescia, ...
Medicine 95 (40), e4519, 2016
282016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20